Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1 More Arrow 244 More Arrow 1,206
Earnings before taxes -5,901 Less Arrow -11,593 Less Arrow -57,260
EBITDA -6,123 More Arrow -5,526 More Arrow -2,437
Total assets 108,845 More Arrow 123,748 Less Arrow 60,133
Current assets 23,004 More Arrow 56,836 Less Arrow 23,699
Current liabilities 9,508 More Arrow 20,372 Less Arrow 3,877
Equity capital 44,164 More Arrow 49,180 Less Arrow 5,650
- share capital 137 Less Arrow 135 Less Arrow 75
Employees (average) 17 Less Arrow 14 Equal arrow 14

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.6% Less Arrow 39.7% Less Arrow 9.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -5.4% Less Arrow -9.2% Less Arrow -93.2%
Current ratio 241.9% More Arrow 279.0% More Arrow 611.3%
Return on equity (ROE) -13.4% Less Arrow -23.6% Less Arrow -1013.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 3 Less Arrow 0 More Arrow 1
Chg. No. of employees % 21% Less Arrow 0% More Arrow 8%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.